From prior authorization barriers to population health gaps, Cheeley explains why adherence — not initiation — is where pharmacists can make their biggest impact.
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Advertisement
Articles by Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA, highlights key data and events at the 2026 NLA Scientific Sessions.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
A Paradigm Shift in Lipid Management: Highlights from the NLA 2026 Scientific Sessions Opening Session
2
ATTR-CM Red Flags, Treatment Evidence, and the Pharmacist's Role in Care
3
Tarlatamab Improves Intracranial Outcomes and May Overcome Poor Prognosis in Relapsed SCLC With Brain Metastases
4
Anticoagulation in AFib: Risk Stratification, Therapy Selection, and Factor XI Inhibitors
5